Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 1999Growth Factors

Thrombopoietin

View Full Paper
Ask AI
Bookmark
Share

Design

Review

Authors

WAWarren S. Alexander

Discussion

Loading...

Member takes

Overview

May support Mpl-ligands in thrombocytopenia; leaves open optimal dosing and long-term outcomes in broader populations.

Structured PICO

I
Intervention
Thrombopoietin (TPO) and Mpl-ligands

Thrombopoietin and its receptor c-Mpl are key regulators of platelet production, offering therapeutic potential for treating thrombocytopenia.

Cite This Study

Warren S. Alexander (1999) studied this question.

synapsesocial.com/papers/6a7dd912d0946debe915053dhttps://doi.org/10.3109/08977199909001059
View Full Paper
Ask AI
Bookmark
Share